• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏拓扑异构酶I的哺乳动物细胞中丝氨酸/精氨酸丰富蛋白磷酸化及外显子增强子依赖性剪接的改变

Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.

作者信息

Soret Johann, Gabut Mathieu, Dupon Cecile, Kohlhagen Glenda, Stévenin James, Pommier Yves, Tazi Jamal

机构信息

Institut de Génétique Moléculaire, Centre National de la Recherche Scientifique/UMR5535, and Institut Fédératif de Recherches 122 Montpellier, France.

出版信息

Cancer Res. 2003 Dec 1;63(23):8203-11.

PMID:14678976
Abstract

DNA topoisomerase I (Topo I) specifically phosphorylates arginine-serine-rich (SR proteins) splicing factors and is potentially involved in pre-mRNA-splicing regulation. Using a Topo I-deficient murine B lymphoma-derived subclone (P388-45/C) selected for its resistance to high dosage of the antitumor drug camptothecin, we show that Topo I depletion results in the hypophosphorylation of SR proteins and impairs exonic splicing enhancer (ESE)-dependent but not constitutive splicing. The Affymetrix GeneChip system analysis revealed that several alternatively spliced genes, characterized by small exons and large introns, are down-regulated in Topo I-deficient cells. Given that ectopic expression of green fluorescent protein-Topo I fusion in Topo I-deficient cells restores both wild-type phosphorylation of SR proteins and ESE-dependent splicing, we conclude that Topo I-mediated phosphorylation plays a specific role in ESE-regulated splicing.

摘要

DNA拓扑异构酶I(Topo I)特异性地使富含精氨酸 - 丝氨酸(SR蛋白)的剪接因子磷酸化,并可能参与前体mRNA剪接调控。我们使用一个因对高剂量抗肿瘤药物喜树碱具有抗性而筛选出的Topo I缺陷型小鼠B淋巴瘤衍生亚克隆(P388 - 45/C),发现Topo I缺失导致SR蛋白的磷酸化不足,并损害外显子剪接增强子(ESE)依赖的剪接,但不影响组成型剪接。Affymetrix基因芯片系统分析显示,几个以小外显子和大内元为特征的可变剪接基因在Topo I缺陷细胞中表达下调。鉴于在Topo I缺陷细胞中绿色荧光蛋白 - Topo I融合蛋白的异位表达可恢复SR蛋白的野生型磷酸化和ESE依赖的剪接,我们得出结论,Topo I介导的磷酸化在ESE调控的剪接中起特定作用。

相似文献

1
Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.缺乏拓扑异构酶I的哺乳动物细胞中丝氨酸/精氨酸丰富蛋白磷酸化及外显子增强子依赖性剪接的改变
Cancer Res. 2003 Dec 1;63(23):8203-11.
2
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.抗肿瘤药物NB-506对富含丝氨酸和精氨酸的剪接因子磷酸化、剪接体组装及剪接的特异性抑制作用
Cancer Res. 2001 Sep 15;61(18):6876-84.
3
A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.拓扑异构酶I部分重复导致耐药性产生的新机制。
Cancer Res. 1999 Jun 1;59(11):2701-8.
4
Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.Kep1蛋白的磷酸化状态改变了其与蛋白结合伴侣可变剪接因子ASF/SF2的亲和力。
Biochem J. 2006 Nov 15;400(1):91-7. doi: 10.1042/BJ20060384.
5
SR protein kinases: the splice of life.SR蛋白激酶:生命的剪接
Biochem Cell Biol. 1999;77(4):293-8.
6
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.哺乳动物DNA拓扑异构酶I对SR蛋白的特异性磷酸化作用。
Nature. 1996 May 2;381(6577):80-2. doi: 10.1038/381080a0.
7
SR-related proteins and the processing of messenger RNA precursors.与SR相关的蛋白质和信使RNA前体的加工
Biochem Cell Biol. 1999;77(4):277-91.
8
Functional expression of human DNA topoisomerase I and its subcellular localization in HeLa cells.人DNA拓扑异构酶I在HeLa细胞中的功能表达及其亚细胞定位
Exp Cell Res. 2000 May 1;256(2):480-90. doi: 10.1006/excr.2000.4864.
9
Functional distribution and dynamics of Arabidopsis SR splicing factors in living plant cells.拟南芥SR剪接因子在活植物细胞中的功能分布及动态变化
Plant J. 2005 Feb;41(4):567-82. doi: 10.1111/j.1365-313X.2004.02321.x.
10
Alternative splicing of pre-mRNAs of Arabidopsis serine/arginine-rich proteins: regulation by hormones and stresses.拟南芥富含丝氨酸/精氨酸蛋白前体mRNA的可变剪接:激素和胁迫的调控
Plant J. 2007 Mar;49(6):1091-107. doi: 10.1111/j.1365-313X.2006.03020.x. Epub 2007 Feb 22.

引用本文的文献

1
R-loops, type I topoisomerases and cancer.R环、I型拓扑异构酶与癌症
NAR Cancer. 2023 Mar 3;5(1):zcad013. doi: 10.1093/narcan/zcad013. eCollection 2023 Mar.
2
Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors.前体mRNA剪接的调控:剪接因子翻译后修饰的不可或缺的作用。
Life (Basel). 2023 Feb 21;13(3):604. doi: 10.3390/life13030604.
3
Comparative genomics of the coconut crab and other decapod crustaceans: exploring the molecular basis of terrestrial adaptation.椰子蟹与其他十足目甲壳动物的比较基因组学:探索陆地适应的分子基础。
BMC Genomics. 2021 Apr 30;22(1):313. doi: 10.1186/s12864-021-07636-9.
4
Why Should DNA Topoisomerase I Have a Scaffold Activity?为什么DNA拓扑异构酶I会具有支架活性?
Biology (Basel). 2021 Mar 3;10(3):190. doi: 10.3390/biology10030190.
5
When SUMO met splicing.当 SUMO 遇到剪接。
RNA Biol. 2018;15(6):689-695. doi: 10.1080/15476286.2018.1457936. Epub 2018 May 9.
6
Artemisinin Derivatives Target Topoisomerase 1 and Cause DNA Damage and .青蒿素衍生物靶向拓扑异构酶1并导致DNA损伤以及…… (原文最后“and”后面内容不完整)
Front Pharmacol. 2017 Oct 9;8:711. doi: 10.3389/fphar.2017.00711. eCollection 2017.
7
Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.低剂量乙氧啶在小鼠缺血后肢模型中的促血管生成作用:乙氧啶水平与一氧化氮途径激活增加之间的相关性
Molecules. 2017 Apr 12;22(4):627. doi: 10.3390/molecules22040627.
8
DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.DNA依赖蛋白激酶(DNA-PK)在修复转录阻断型拓扑异构酶I损伤过程中产生的DNA双链断裂时,触发组蛋白泛素化和信号传导。
Nucleic Acids Res. 2016 Feb 18;44(3):1161-78. doi: 10.1093/nar/gkv1196. Epub 2015 Nov 17.
9
Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology.剪接因子SRSF1的转录后调控及其在癌细胞生物学中的作用
Biomed Res Int. 2015;2015:287048. doi: 10.1155/2015/287048. Epub 2015 Jul 26.
10
Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.全基因组慢病毒shRNA筛选确定富含丝氨酸/精氨酸的剪接因子2是乳腺癌细胞中溶瘤病毒活性的决定因素。
Oncogene. 2016 May 12;35(19):2465-74. doi: 10.1038/onc.2015.303. Epub 2015 Aug 10.